Stay updated on FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page.

Latest updates to the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page
- Check7 days agoChange DetectedCore study content remains unchanged between screenshots; any visible differences are limited to formatting or layout rather than study details. No additions or deletions affecting the trial information were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedUpdated operational notice and version to v3.2.0; removed two cancer-type items (Cutaneous neuroendocrine carcinoma, Small cell lung carcinoma) and prior version tag v3.1.0; added links to status pages.SummaryDifference3%

- Check35 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

- Check50 days agoChange DetectedUpdated to v3.0.2 (replacing v3.0.1) and removed the Back to Top link, indicating a release update with a small UI cleanup.SummaryDifference0.2%

- Check57 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check64 days agoChange DetectedThe web page has been updated to include new drug information and resources related to various cancers, while removing outdated genetic resources and specific drug classifications. Notably, the facility name and location details have been added, enhancing the page's relevance and accuracy.SummaryDifference14%

Stay in the know with updates to FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page.